White House Says Trump Will Meet With Rosenstein Thursday
*By Christian Smith*
Deputy Attorney General Rod Rosenstein reportedly offered his verbal resignation to White House Chief of Staff John Kelly on Monday but was told to wait for the president. As of Monday evening, he still has a job ー for now.
Rosenstein's undetermined fate will have consequences for Robert Mueller's Russia investigation, said Jonna Spilbor, a former prosecutor.
"I think it is going to affect the Mueller investigation in a good way for all of those who think that this investigation has been one long run-on sentence that we need to put a period at the end of," Spilbor said Monday in an interview on Cheddar.
Several reports suggested Rosenstein would either resign or be fired Monday ー following an explosive piece in The New York Times last week that he had considered secretly taping conversations with the president and discussed soliciting cabinet members to invoke the 25th Amendment, which would start impeachment proceedings. White House Press Secretary Sarah Huckabee Sanders told reporters that Trump will meet with Rosenstein on Thursday after the president's return from the United Nations General Assembly in New York.
In the event that Rosenstein is fired, a replacement might re-invigorate the Russia probe, Spilbor said.
"The replacement for Rod Rosenstein will say, 'Ok, you've got 30 days,' ー let's pick an arbitrary number ー 'Give me my report because at the end of that 30 days, I'm going to decide if you live or die,'" Spilbor said.
The Justice Department appointed former FBI Director Robert Mueller as special counsel on May 17 of last year to lead an investigation into Russian interference in the 2016 U.S. presidential election. Multiple Trump campaign officials have pleaded guilty to charges ranging from bank fraud to obstruction of justice, but no charges related to Russian collusion have been filed ー which is why Spilbor believes the investigation is dragging.
"The investigation has been going on far too long and with far too few results. Why do we keep it going?" Spilbor said.
For full interview [click here](https://cheddar.com/videos/how-rosensteins-possible-doj-departure-could-impact-the-russia-investigation).
Jill and Carlo cover the latest on Omicron, another school shooting in America and more. Plus, bidding farewell to 'transitory' inflation, and the controversy surrounding 'Lovely Bones' author Alice Sebold.
Disparities in tree coverage across America is a huge issue that affects air quality, heat exposure, and ultimately determines how resilient communities are against climate change. The Build Back Better Act is allocating $2.5 billion to boost 'tree equity.' Lemir Teron, assistant professor at SUNY College of Environmental Science and Forestry, joins Cheddar News to explain why this is a priority for Democrats today.
The Supreme Court will be hearing arguments in Dobbs v. Jackson Women's Health on Wednesday over a Mississippi law banning abortions after 15 weeks. Jimmy Hoover, the Supreme Court editor-at-large for Law360, joined Cheddar to break down the momentous legal fight. "This is the biggest abortion case at the Supreme Court in 30 years," he said. "It is a … a direct challenge to Roe v. Wade."
Matt Peron, Director of Research at Janus Henderson Investors, joins Cheddar News' Closing Bell, where he breaks down the factors leading to today's market slide and says there's more to it than Fed Chair Jerome Powell's comments about speeding up tapering efforts.
Walmart CEO Dough McMillon praised the Biden administration's efforts to ease supply chain constraints after the company saw a 26 percent jump in shipments over the last month. President Joe Biden had announced back in October that California ports would operate on a 24/7 basis.
Jill and Carlo cover the latest developments with the Omicron variant that are spooking markets once again. Twitter's @Jack is leaving, SCOTUS takes up abortion rights and the world has a brand new republic.
The Biden Administration is set to buy 10 million courses of Pfizer's Covid pill if it gains emergency use authorization from the FDA. With this purchase, the U.S. will receive more than 13 million courses of antiviral pills aimed at treating Covid and reducing severe illness and death. Pfizer's pill has been shown to reduce risk of hospitalization and death by 89 percent, proving it could be a key tool in the fight against the pandemic. Dr. Soumi Eachempati, Co-Founder, CEO & CMO of Cleared4, joined Cheddar News to discuss.
